Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Assessment of the clinical effects of infusions of cryopreserved allogeneic multipotent mesenchymal stem cells of the placenta and umbilical cord for COVID-19 patients with acute respiratory distress syndrome.
Epistemonikos ID: b8097ad5cf9fdcabceb87c79e4c37ab9e2e77956
First added on: Jul 09, 2020